Windtree Therapeutics, Inc. Profile Avatar - Palmy Investing

Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include ist…

Biotechnology
US, Warrington [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of WINT's Analysis
CIK: 946486 CUSIP: 97382D303 ISIN: US97382D4025 LEI: - UEI: -
Secondary Listings
WINT has no secondary listings inside our databases.